United States Hepatitis A Vaccine Market Report 2017

October 2017 | 110 pages | ID: U18CB2819FEEN
QYResearch

Abstracts

In this report, the United States Hepatitis A Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Hepatitis A Vaccine in these regions, from 2012 to 2022 (forecast).

United States Hepatitis A Vaccine market competition by top manufacturers/players, with Hepatitis A Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Merck Sharp & Dohme Corp
• SANOFI PASTEUR S.A
• Norvatis
• Crucell Switzerland AG(Berna+Crucell)
• China Academy of Medical Sciences
• Changchun Institute of Biological Products
• Zhejiang Pukang
• ChangSheng
• Sinovac
• Shanghai Zerun Biotechnology

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Liver Inactivated Vaccine
• Live Attenuated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hepatitis A Vaccine for each application, including

• Hospitals
• Other Medical Institutions

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Hepatitis A Vaccine Market Report 2017

1 HEPATITIS A VACCINE OVERVIEW

1.1 Product Overview and Scope of Hepatitis A Vaccine
1.2 Classification of Hepatitis A Vaccine by Product Category
  1.2.1 United States Hepatitis A Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Hepatitis A Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Liver Inactivated Vaccine
  1.2.4 Live Attenuated Vaccine
1.3 United States Hepatitis A Vaccine Market by Application/End Users
  1.3.1 United States Hepatitis A Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Other Medical Institutions
1.4 United States Hepatitis A Vaccine Market by Region
  1.4.1 United States Hepatitis A Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Hepatitis A Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Hepatitis A Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Hepatitis A Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Hepatitis A Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Hepatitis A Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Hepatitis A Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hepatitis A Vaccine (2012-2022)
  1.5.1 United States Hepatitis A Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Hepatitis A Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEPATITIS A VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hepatitis A Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hepatitis A Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hepatitis A Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Hepatitis A Vaccine Market Competitive Situation and Trends
  2.4.1 United States Hepatitis A Vaccine Market Concentration Rate
  2.4.2 United States Hepatitis A Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hepatitis A Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEPATITIS A VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Hepatitis A Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Hepatitis A Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Hepatitis A Vaccine Price by Region (2012-2017)

4 UNITED STATES HEPATITIS A VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Hepatitis A Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hepatitis A Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Hepatitis A Vaccine Price by Type (2012-2017)
4.4 United States Hepatitis A Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEPATITIS A VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hepatitis A Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Hepatitis A Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEPATITIS A VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck Sharp & Dohme Corp
  6.2.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 SANOFI PASTEUR S.A
  6.3.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 SANOFI PASTEUR S.A Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Norvatis
  6.4.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Norvatis Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Crucell Switzerland AG(Berna+Crucell)
  6.5.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 China Academy of Medical Sciences
  6.6.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 China Academy of Medical Sciences Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Changchun Institute of Biological Products
  6.7.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Changchun Institute of Biological Products Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Zhejiang Pukang
  6.8.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 ChangSheng
  6.9.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sinovac
  6.10.2 Hepatitis A Vaccine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Shanghai Zerun Biotechnology

7 HEPATITIS A VACCINE MANUFACTURING COST ANALYSIS

7.1 Hepatitis A Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hepatitis A Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hepatitis A Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hepatitis A Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEPATITIS A VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Hepatitis A Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hepatitis A Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Hepatitis A Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Hepatitis A Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hepatitis A Vaccine
Figure United States Hepatitis A Vaccine Market Size (K Units) by Type (2012-2022)
Figure United States Hepatitis A Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Liver Inactivated Vaccine Product Picture
Figure Live Attenuated Vaccine Product Picture
Figure United States Hepatitis A Vaccine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Hepatitis A Vaccine by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Other Medical Institutions Examples
Table Key Downstream Customer in Other Medical Institutions
Figure United States Hepatitis A Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Hepatitis A Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hepatitis A Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hepatitis A Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hepatitis A Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hepatitis A Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hepatitis A Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis A Vaccine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Hepatitis A Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis A Vaccine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Hepatitis A Vaccine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Hepatitis A Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis A Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Hepatitis A Vaccine Sales Share by Players/Suppliers
Figure United States Hepatitis A Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hepatitis A Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hepatitis A Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis A Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Hepatitis A Vaccine Revenue Share by Players/Suppliers
Table United States Market Hepatitis A Vaccine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Hepatitis A Vaccine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Hepatitis A Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Hepatitis A Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hepatitis A Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hepatitis A Vaccine Product Category
Table United States Hepatitis A Vaccine Sales (K Units) by Region (2012-2017)
Table United States Hepatitis A Vaccine Sales Share by Region (2012-2017)
Figure United States Hepatitis A Vaccine Sales Share by Region (2012-2017)
Figure United States Hepatitis A Vaccine Sales Market Share by Region in 2016
Table United States Hepatitis A Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hepatitis A Vaccine Revenue Share by Region (2012-2017)
Figure United States Hepatitis A Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Hepatitis A Vaccine Revenue Market Share by Region in 2016
Table United States Hepatitis A Vaccine Price (USD/Unit) by Region (2012-2017)
Table United States Hepatitis A Vaccine Sales (K Units) by Type (2012-2017)
Table United States Hepatitis A Vaccine Sales Share by Type (2012-2017)
Figure United States Hepatitis A Vaccine Sales Share by Type (2012-2017)
Figure United States Hepatitis A Vaccine Sales Market Share by Type in 2016
Table United States Hepatitis A Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hepatitis A Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hepatitis A Vaccine by Type (2012-2017)
Figure Revenue Market Share of Hepatitis A Vaccine by Type in 2016
Table United States Hepatitis A Vaccine Price (USD/Unit) by Types (2012-2017)
Figure United States Hepatitis A Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Hepatitis A Vaccine Sales (K Units) by Application (2012-2017)
Table United States Hepatitis A Vaccine Sales Market Share by Application (2012-2017)
Figure United States Hepatitis A Vaccine Sales Market Share by Application (2012-2017)
Figure United States Hepatitis A Vaccine Sales Market Share by Application in 2016
Table United States Hepatitis A Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Hepatitis A Vaccine Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Sharp & Dohme Corp Basic Information List
Table Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Sharp & Dohme Corp Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table SANOFI PASTEUR S.A Basic Information List
Table SANOFI PASTEUR S.A Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SANOFI PASTEUR S.A Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure SANOFI PASTEUR S.A Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure SANOFI PASTEUR S.A Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table Norvatis Basic Information List
Table Norvatis Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Norvatis Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure Norvatis Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure Norvatis Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table Crucell Switzerland AG(Berna+Crucell) Basic Information List
Table Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table China Academy of Medical Sciences Basic Information List
Table China Academy of Medical Sciences Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure China Academy of Medical Sciences Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure China Academy of Medical Sciences Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure China Academy of Medical Sciences Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table Changchun Institute of Biological Products Basic Information List
Table Changchun Institute of Biological Products Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Changchun Institute of Biological Products Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure Changchun Institute of Biological Products Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure Changchun Institute of Biological Products Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table Zhejiang Pukang Basic Information List
Table Zhejiang Pukang Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zhejiang Pukang Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure Zhejiang Pukang Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure Zhejiang Pukang Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table ChangSheng Basic Information List
Table ChangSheng Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ChangSheng Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure ChangSheng Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure ChangSheng Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table Sinovac Basic Information List
Table Sinovac Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sinovac Hepatitis A Vaccine Sales Growth Rate (2012-2017)
Figure Sinovac Hepatitis A Vaccine Sales Market Share in United States (2012-2017)
Figure Sinovac Hepatitis A Vaccine Revenue Market Share in United States (2012-2017)
Table Shanghai Zerun Biotechnology Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis A Vaccine
Figure Manufacturing Process Analysis of Hepatitis A Vaccine
Figure Hepatitis A Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis A Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Hepatitis A Vaccine
Table Distributors/Traders List
Figure United States Hepatitis A Vaccine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis A Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis A Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Hepatitis A Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hepatitis A Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hepatitis A Vaccine Sales Volume (K Units) Forecast by Type in 2022
Table United States Hepatitis A Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hepatitis A Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hepatitis A Vaccine Sales Volume (K Units) Forecast by Application in 2022
Table United States Hepatitis A Vaccine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Hepatitis A Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis A Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis A Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources